{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:44:02Z","timestamp":1777380242419,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Research and Human Retroviruses"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>District of Columbia (DC) has high rates of HIV infection and human papillomavirus (HPV)-associated cancers. People living with HIV (PLWH) are at risk for developing HPV-associated cancers. Previous studies identified factors that may further increase the risk of HPV-associated cancer among PLWH such as age, race\/ethnicity, sex, risk factor for HIV transmission, stage of HIV infection, and age at HIV diagnosis. The extent to which PLWH in DC are affected by HPV-associated cancers has not previously been well described, and to our knowledge, the relationship between bacterial sexually transmitted infections (STIs) and subsequent development of HPV-associated cancer among PLWH in DC has not been explored. This was a retrospective case\u2013control analysis of surveillance data on cancer, STIs, and HIV in Washington, DC from 1996 to 2015. There were 20,744 PLWH included in this study, of whom 335 (1.6%) had been diagnosed with an HPV-associated cancer. Among males living with HIV (MLWH), for every additional STI per 10 person-years, risk of developing an HPV-associated cancer increased by 11%. Exposure to STIs was not a significant risk factor for HPV-associated cancer among females. Ever being diagnosed with stage three HIV infection increased risk of HPV-associated cancers among males by 109% and females living with HIV by 111%. STI exposures were associated with HPV-associated cancers among MLWH in DC and ever being diagnosed with advanced HIV infection was associated with HPV-associated cancers among all PLWH. Clinicians treating MLWH should ensure their patients receive primary HPV infection prevention and HPV-associated cancer screenings.<\/jats:p>","DOI":"10.1089\/aid.2022.0128","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T12:16:42Z","timestamp":1674130602000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk Factors for Human Papillomavirus-Associated Cancers Among People Living with HIV in Washington, District of Columbia"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-4075","authenticated-orcid":false,"given":"Ansley V.","family":"Waters","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Milken School of Public Health, George Washington University, Washington, District of Columbia, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri A.","family":"Dorsey","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Milken School of Public Health, George Washington University, Washington, District of Columbia, USA."},{"name":"HIV\/AIDS, Hepatitis, STD and TB Administration, District of Columbia Department of Health, Washington, District of Columbia, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Allston","sequence":"additional","affiliation":[{"name":"HIV\/AIDS, Hepatitis, STD and TB Administration, District of Columbia Department of Health, Washington, District of Columbia, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfreda","family":"Woods","sequence":"additional","affiliation":[{"name":"District of Columbia Cancer Registry, District of Columbia Department of Health, Washington, District of Columbia, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce W.","family":"Furness","sequence":"additional","affiliation":[{"name":"HIV\/AIDS, Hepatitis, STD and TB Administration, District of Columbia Department of Health, Washington, District of Columbia, USA."},{"name":"Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupali K.","family":"Doshi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Milken School of Public Health, George Washington University, Washington, District of Columbia, USA."},{"name":"HIV\/AIDS, Hepatitis, STD and TB Administration, District of Columbia Department of Health, Washington, District of Columbia, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6526a1"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/154407370601900120"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.24875\/AIDSRev.M18000021"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1500"},{"key":"e_1_3_5_6_2","unstructured":"Annual epidemiology and surveillance report: Data through December 2018. District of Columbia Department of Health HIV\/AIDS Hepatitis STD and TB Administration 2019. Available from: https:\/\/dchealth.dc.gov\/publication\/hahsta-annual-epidemiology-surveillance-report-2019 [Last accessed: March 15 2022]."},{"key":"e_1_3_5_7_2","unstructured":"HIV in the United States by region. Centers for Disease Control and Prevention October 26 2020. Available from: https:\/\/www.cdc.gov\/hiv\/statistics\/overview\/geographicdistribution.html [Last accessed: March 15 2022]."},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp205"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs371"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9291"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328331f6e2"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23487"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr076"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000238411.75324.59"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181b033ab"},{"key":"e_1_3_5_16_2","unstructured":"HPV and cancer. National Cancer Institute January 10 2020. Available from: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer [Last accessed: March 15 2022]."},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv086"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6833a3"},{"key":"e_1_3_5_19_2","unstructured":"HIV and opportunistic infections coinfections and conditions: HIV and sexually transmitted diseases (STDs). Office of AIDS Research National Institutes of Health September 24 2020. Available from: https:\/\/aidsinfo.nih.gov\/understanding-hiv-aids\/fact-sheets\/26\/98\/hiv-and-sexually-transmitted-diseases\u2014stds- [Last accessed: March 15 2022]."},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000695"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3180eaa243"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2009.0255"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000614"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0394"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199107000-00004"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00024.x"},{"key":"e_1_3_5_27_2","unstructured":"De-duplication guidance for gonorrhea and chlamydia laboratory reports. Centers for Disease Control and Prevention 2016. Available from: https:\/\/www.cdc.gov\/std\/laboratory\/De-duplication-guidance-June2016.pdf [Last accessed: March 15 2022]."},{"key":"e_1_3_5_28_2","unstructured":"Blake SM Ledsky R Whycoff V et al. Health & risk behaviors of District of Columbia youth: The youth risk behavior survey report 2007. The Office of the State Superintendent of Education (OSSE) Office of Wellness and Nutrition Services (WNS) June 2010."},{"issue":"03","key":"e_1_3_5_29_2","first-page":"1","article-title":"Revised surveillance case definition for HIV infection\u2014United States, 2014","volume":"63","author":"Selik RM","year":"2014","unstructured":"Selik RM, , Mokotoff ED, , Branson B, et al. Revised surveillance case definition for HIV infection\u2014United States, 2014. MMWR Morb Mortal Wkly Rep, 2014; 63(RR03):1\u201310.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(96)00378-x"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12365"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.06.007"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2021.01805"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416020-01038-6"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952999209051037"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12403"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104614"},{"key":"e_1_3_5_38_2","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Human papillomavirus disease. Office of AIDS Research National Institutes of Health August 18 2021. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection\/human-papillomavirus-disease?view=full [Last accessed: March 15 2022]."},{"key":"e_1_3_5_39_2","unstructured":"Performance Measure Portfolio. Ryan White HIV\/AIDS Program Health Research and Services Administration June 2020. Available from: https:\/\/hab.hrsa.gov\/clinical-quality-management\/performance-measure-portfolio [Last accessed: March 15 2022]."}],"container-title":["AIDS Research and Human Retroviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/aid.2022.0128","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2022.0128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2022.0128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:16:47Z","timestamp":1777367807000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/aid.2022.0128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1089\/aid.2022.0128"],"URL":"https:\/\/doi.org\/10.1089\/aid.2022.0128","relation":{},"ISSN":["0889-2229","1931-8405"],"issn-type":[{"value":"0889-2229","type":"print"},{"value":"1931-8405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}